Robert W. Selander Sells 5,750 Shares of HealthEquity, Inc. (NASDAQ:HQY) Stock

HealthEquity, Inc. (NASDAQ:HQY) Director Robert W. Selander sold 5,750 shares of the firm’s stock in a transaction on Wednesday, April 9th. The shares were sold at an average price of $77.65, for a total value of $446,487.50. Following the completion of the sale, the director now owns 84,969 shares in the company, valued at approximately $6,597,842.85. This represents a 6.34 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.

HealthEquity Trading Up 2.8 %

NASDAQ:HQY opened at $82.20 on Friday. HealthEquity, Inc. has a 12-month low of $65.01 and a 12-month high of $115.59. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51. The stock’s 50 day simple moving average is $97.63 and its 200-day simple moving average is $96.30. The firm has a market cap of $7.11 billion, a P/E ratio of 75.41, a PEG ratio of 1.60 and a beta of 0.49.

Institutional Trading of HealthEquity

Several hedge funds have recently made changes to their positions in HQY. Arcadia Investment Management Corp MI purchased a new position in HealthEquity during the fourth quarter worth about $26,000. Versant Capital Management Inc acquired a new position in HealthEquity during the 1st quarter worth approximately $28,000. Transce3nd LLC purchased a new position in HealthEquity in the fourth quarter worth $29,000. Smartleaf Asset Management LLC lifted its holdings in HealthEquity by 34.3% in the fourth quarter. Smartleaf Asset Management LLC now owns 384 shares of the company’s stock valued at $37,000 after acquiring an additional 98 shares during the period. Finally, Proficio Capital Partners LLC purchased a new stake in shares of HealthEquity during the 4th quarter worth $39,000. Institutional investors and hedge funds own 99.55% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on the stock. The Goldman Sachs Group cut their price objective on shares of HealthEquity from $107.00 to $94.00 and set a “neutral” rating on the stock in a report on Thursday, March 27th. Raymond James upgraded shares of HealthEquity from an “outperform” rating to a “strong-buy” rating and cut their price target for the stock from $120.00 to $115.00 in a research note on Tuesday, March 25th. Wells Fargo & Company upped their price objective on shares of HealthEquity from $110.00 to $125.00 and gave the company an “overweight” rating in a research note on Wednesday, February 26th. Barrington Research reiterated an “outperform” rating and set a $112.00 target price on shares of HealthEquity in a research report on Friday. Finally, KeyCorp reduced their target price on HealthEquity from $120.00 to $110.00 and set an “overweight” rating for the company in a report on Monday, March 24th. One investment analyst has rated the stock with a hold rating, ten have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, HealthEquity has an average rating of “Buy” and an average price target of $112.58.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.